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normal ovaries. This study was undertaken to establish the current practice of prophylactic oophorectomy in Northern Ireland.
METHODS
In Northern Ireland there are seventeen hospitals which perform gynaecological surgery. A postal questionnaire was sent to all consultant gynaecologists (n = 42) and gynaecological senior registrars (n = 8). In order to encourage the response rate, replies were anonymous and postage was prepaid. This study was carried out during a six week period of 1988. RESULTS Forty three (84%) replies were received and the results are summarised in the Table. Prophylactic oophorectomy during hysterectomy was performed at some time by up to 72% of gynaecologists. Their practice was dependent on the patient's age and menopausal status, with a natural transition appearing between the ages of 40 and 45. Unilateral prophylactic oophorectomy was carried out by 28% of the sample and was generally performed when the patient was aged between 40 and 45 years. A second group of sufgeons (26%) never removed normal ovaries as a prophylactic procedure during hysterectomy. If prophylactic oophorectomy was performed before the menopause 12 (57%) prescribed hormone replacement therapy, whereas 7 (33%) prescribed this only if the patient became symptomatic. Two surgeons (10 %) used oestradiol implants at the time of surgery. The Ulster Medical Journal surgical procedure itself. From this study it appears that there is wide variation in attitudes to prophylactic oophorectomy, a finding which is not unique to Northern Ireland.7 A review of the literature indicates that the need for prophylactic oophorectomy has been questioned many times, with no clear answer.8 How many patients with retained ovaries actually develop carcinoma of the ovary? Jacobs and Oram9 recently reviewed twelve studies in which the average incidence of cancer in retained ovaries, after surgery for benign gynaecological disease, was 0-2 %. This seems a very small and quite acceptable figure. However, all of these studies suffer from the fact that long term (greater than 10 years) follow-up is difficult due to population mobility, and a woman may die from an unrelated disease and an ovarian tumour remain undiscovered. The second approach is to examine how many patients with ovarian carcinoma have undergone previous pelvic surgery where prophylactic oophorectomy could have been performed. Studies of this question give figures ranging from 4-5 % 10 to 14%," an average figure from twelve studies is 10%. Opponents of prophylactic oophorectomy suggest that, using these arguments, general surgeons should perform prophylactic mastectomy to reduce breast carcinoma and remove testicles at the time of inguinal hernia repair. In reply, it should be remembered that the ovary is a hidden organ, in which cancer is more comparable to that of the pancreas than to cancer of the breast or testis.
In the absence of better diagnostic and therapeutic procedures for ovarian disorders, I would suggest that prophylactic oophorectomy be used to reduce both benign and malignant ovarian disease. It should be considered by all those operating in the female pelvis and should be planned prior to surgery with the patient partaking in the decision -making process. Current gynaecological practice in Northern Ireland shows that a majority of surgeons consider that ovaries should be removed during any pelvic surgery after the menopause and that in the pre -menopausal patient over the age of 40, prophylactic oophorectomy is an option which must be considered, especially if there is a strong family history of ovarian cancer or there are other high -risk features.
Regarding the practice of unilateral prophylactic oophorectomy, review of the literature reveals no benefit from performing such a procedure and in theory it may even be detrimental.
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